Huimin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Huimin Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Chunmei Zhao
Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
1 shared publicationChunyan Xia
Department of Pathology, Changzheng Hospital, Second Military Medical University * Department of Pathology, Changzheng Hospital. No.415, Fengyang Road, Shanghai, 200003, China
1 shared publicationGuihua Wang
Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
1 shared publicationJin He
Department of Pathology, Changzheng Hospital, Second Military Medical University * Department of Pathology, Changzheng Hospital. No.415, Fengyang Road, Shanghai, 200003, China
1 shared publicationJing Chen
Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
1 shared publication- Junhui Ge
Department of Pathology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
1 shared publication
Latest Publications
- 19 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 2454-2468
Identification specific miRNA in t(4;14) multiple myeloma based on miRNA‐mRNA expressing profile correlation analysis
Background: Multiple myeloma (MM) is a common malignancy belonging to the hematological system. The translocation t(4;14)(p16.3;q32.3) is a critical cytogenetic change of MM, which is presenting a poor prognosis. The specific microRNAs (miRNAs) that are involved in t(4;14) myeloma are still unknown. Thus, the main purpose of this research was to identify specific miRNAs in t(4;14) positive myeloma.Methods: The expression profiles of miRNA and messenger RNA (mRNA) in t(4; 14) positive and negative samples were obtained from the gene expression omnibus data series. The miRNA‐mRNA regulatory network was constructed based on two self‐defined regulation models. Subsequently, we performed the topology analysis for mining the hub genes, and Pearson’s correlation coefficient analysis was used to calculate the relevance of the hub genes and specific miRNAs.Results: Thirteen differentially expressed miRNAs and 206 differential mRNAs were extracted between t(4;14) positive group and negative group. The network consisted of 8 miRNAs and 154 mRNAs in 2 reverse regulated models, which showed a total of 485 interactions, including 376 cis‐regulated and 109 trans‐regulated relationships. The miR‐125a‐3p, miR‐125a‐5p, miR‐99b‐5p, and let‐7e were powerful miRNAs correlating with the FGFR3, MAP1B, MYRIP, and CDC42BPA under the relevance analysis in the subnetwork.Conclusion: In our study, a distinctive correlation analysis of miRNA‐mRNA was established to excavate specific miRNAs and hub target mRNAs in patients with t(4;14), but it was only a matter of theoretical principles. The further experimental explorations are needed to confirm valuable diagnostic and therapeutic symbols specific associated with t(4;14) in the future.
- 19 September 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (2) , 2454-2468
Identification specific miRNA in t(4;14) multiple myeloma based on miRNA‐mRNA expressing profile correlation analysis
Background: Multiple myeloma (MM) is a common malignancy belonging to the hematological system. The translocation t(4;14)(p16.3;q32.3) is a critical cytogenetic change of MM, which is presenting a poor prognosis. The specific microRNAs (miRNAs) that are involved in t(4;14) myeloma are still unknown. Thus, the main purpose of this research was to identify specific miRNAs in t(4;14) positive myeloma.Methods: The expression profiles of miRNA and messenger RNA (mRNA) in t(4; 14) positive and negative samples were obtained from the gene expression omnibus data series. The miRNA‐mRNA regulatory network was constructed based on two self‐defined regulation models. Subsequently, we performed the topology analysis for mining the hub genes, and Pearson’s correlation coefficient analysis was used to calculate the relevance of the hub genes and specific miRNAs.Results: Thirteen differentially expressed miRNAs and 206 differential mRNAs were extracted between t(4;14) positive group and negative group. The network consisted of 8 miRNAs and 154 mRNAs in 2 reverse regulated models, which showed a total of 485 interactions, including 376 cis‐regulated and 109 trans‐regulated relationships. The miR‐125a‐3p, miR‐125a‐5p, miR‐99b‐5p, and let‐7e were powerful miRNAs correlating with the FGFR3, MAP1B, MYRIP, and CDC42BPA under the relevance analysis in the subnetwork.Conclusion: In our study, a distinctive correlation analysis of miRNA‐mRNA was established to excavate specific miRNAs and hub target mRNAs in patients with t(4;14), but it was only a matter of theoretical principles. The further experimental explorations are needed to confirm valuable diagnostic and therapeutic symbols specific associated with t(4;14) in the future.
- Open Access
- 2 February 2010
- Published by Wiley in Brain Pathology
- Vol. 20 (2) , 503-506
A 25‐YEAR‐OLD WOMAN WITH A MASS IN THE HIPPOCAMPUS
Angiocentric gliomas (AG) have only recently been described. We encountered a 25-year-old woman with AG who had a history of epilepsy for two years. MRI revealed that there was a solid tumor in the hippocampus. The tumor was totally removed. Histologically, the spindle tumor cells proliferated around small parenchymal vessels with perivascular pseudorosettes. The tumor cells of the hippocampus surface umbilicated forming rosettes. Immunohistochemistry demonstrated positivity for GFAP, Vimentin and S-100, but were negative for neurofilament protein, Syn, CgA and P53. EMA had "dot-like" positive staining. The proliferation index was less than 1%. The location of the tumor and the pathological findings confirm that the diagnose was AG. Epilepsy disappeared after the operation. When fully resected these tumors have a good prognosis.
- 2 February 2010
- Published by Wiley in Brain Pathology
- Vol. 20 (2) , 503-506
Open AccessA 25‐YEAR‐OLD WOMAN WITH A MASS IN THE HIPPOCAMPUS
Angiocentric gliomas (AG) have only recently been described. We encountered a 25-year-old woman with AG who had a history of epilepsy for two years. MRI revealed that there was a solid tumor in the hippocampus. The tumor was totally removed. Histologically, the spindle tumor cells proliferated around small parenchymal vessels with perivascular pseudorosettes. The tumor cells of the hippocampus surface umbilicated forming rosettes. Immunohistochemistry demonstrated positivity for GFAP, Vimentin and S-100, but were negative for neurofilament protein, Syn, CgA and P53. EMA had "dot-like" positive staining. The proliferation index was less than 1%. The location of the tumor and the pathological findings confirm that the diagnose was AG. Epilepsy disappeared after the operation. When fully resected these tumors have a good prognosis.